ELIZABETH ARCHER-COOPER: Open Payments
NPI 1033565676 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,316 in 48 payments from 15 companies in 2025. Trend: 2023 $804 · 2024 $1,955 · 2025 $1,316
Food & beverage: $1,316
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 2 | $358 |
| E.R. Squibb & Sons, L.L.C. | 6 | $213 |
| Alnylam Pharmaceuticals Inc. | 6 | $127 |
| Novartis Pharmaceuticals Corporation | 5 | $104 |
| Amgen Inc. | 5 | $77 |
| Boston Scientific Corporation | 3 | $68 |
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| Abbott Laboratories | 3 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| Merck Sharp & Dohme LLC | 3 | $51 |
Products named: SAPIEN 3 Ultra RESILIA, ONPATTRO, LEQVIO, REPATHA, CAMZYOS, WATCHMAN FLX, FARXIGA, THORATEC HEARTMATE 3 LVAS IMPLANT KIT.
Industry payments across OK — which companies pay providers there.
